Mirae Asset Global ETFs Holdings’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,591
Closed -$55K 3000
2025
Q1
$55K Buy
20,591
+858
+4% +$2.67K ﹤0.01% 2829
2024
Q4
$69.5K Buy
19,733
+836
+4% +$3.79K ﹤0.01% 2831
2024
Q3
$89.6K Buy
+18,897
New +$86.3K ﹤0.01% 2759

Other funds holding ACHV

Mirae Asset Global ETFs Holdings's ACHV Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Achieve Life Sciences (ACHV) in Q2 2025, closing a stake of 20,591 shares — an estimated $55K sold.

Mirae Asset Global ETFs Holdings first reported a position in ACHV in Q3 2024 and held it in 3 quarters. The position peaked at $89.6K in Q3 2024. 65 funds tracked by Wall St. Rank hold ACHV as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Achieve Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 20,591 Achieve Life Sciences shares in Q2 2025, an estimated $55K.
  • Mirae Asset Global ETFs Holdings first reported a position in Achieve Life Sciences in Q3 2024 and held it in 3 quarters.
  • Mirae Asset Global ETFs Holdings's Achieve Life Sciences position peaked at $89.6K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.